Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + amodiaquine for uncomplicated falciparum malaria in Zanzibar
ACTRN12611000426987Phase 4Withdrawn
- Sponsor
- Ministry of Health, Zanzibar
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in Malaria, sponsored by Ministry of Health, Zanzibar. Primary endpoints: Artesunate-amodiaquine treatment failure rate and Adverse event rate. Planned start May 2011; status: withdrawn.
02
Drugs
artesunateamodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12611000426987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000426987.